Anesthesia management for laparoscopic cholecystectomy and choledochoscopy-assisted intrahepatic bile duct stone extraction in a patient with situs inversus totalis, decompensated cirrhosis, and respiratory insufficiency: a case report Authors: Li Chen, Guoao Shi, Yihua Huang, Hengwei Sheng, Xu Dong, Li Kang Published: 2026 ABSTRACT BackgroundSitus inversus totalis (SIT) is a rare congenital anatomical anomaly characterized by mirror-image reversal of thoracic and abdominal organs. Perioperative management becomes particularly challenging when SIT coexists with inferior vena cava (IVC) malformation (e.g., agenesis of the hepatic segment), decompensated cirrhosis, and respiratory insufficiency—a complex scenario for which relevant anesthesia experience is exceedingly limited.Case presentationA 66-year-old female patient with SIT complicated by polysplenia syndrome and agenesis of the hepatic segment of the IVC presented for surgical management of intrahepatic bile duct stones, cholangitis, and obstructive jaundice. Preoperatively, she had Child-Pugh C cirrhosis and respiratory insufficiency. The patient underwent laparoscopic cholecystectomy, choledochoscopic-assisted intrahepatic bile duct stone extraction, and T-tube drainage. The anesthesia strategy comprised mirror-image ECG lead placement, transthoracic echocardiography (TTE) -guided preload assessment utilizing left ventricular end-diastolic area with subsequent optimization of fluid therapy, preferential selection of hepatically non-metabolized drugs, and employing lung-protective ventilation with permissive hypercapnia targeting PaCO₂ ≤ 65 mmHg. The procedure lasted 320 min with stable hemodynamics. The patient was transferred to the intensive care unit (ICU) with the endotracheal tube in situ and was successfully extubated 1 h after admission. She was discharged from the ICU on postoperative day 6, showing improvement in liver function and overall clinical status compared with her preoperative baseline.ConclusionTo our knowledge, this is the first description of anesthesia management for a patient with SIT complicated by Child-Pugh C cirrhosis and respiratory insufficiency, highlighting TTE as an alternative for preload monitoring in the presence of IVC anomalies. Anticipation of anatomical variations and implementation of an individualized anesthesia strategy are critical to ensuring perioperative safety. Background Situs inversus totalis (SIT), a rare congenital anomaly with mirror-image organ arrangement, has an estimated prevalence of 1/10,000–1/20,000 [1]. It is frequently associated with polysplenia syndrome and inferior vena cava (IVC) malformations, including agenesis of the hepatic segment [2]; this anomaly fundamentally alters systemic venous return. These anatomical variations necessitate modified surgical approaches and complicate anesthesia monitoring and intervention. When SIT coexists with decompensated cirrhosis and respiratory insufficiency, the pathophysiological alterations of liver dysfunction (e.g., impaired synthetic function, altered drug metabolism) overlap with impaired pulmonary reserve, elevating perioperative risk to an extreme level. There is a paucity of anesthesia management strategies for laparoscopic biliary surgery in patients with such rare, multisystem comorbidities. Specifically, no prior report has described anesthesia for a patient with SIT, agenesis of the hepatic segment of the IVC with azygos continuation, Child-Pugh C cirrhosis, and respiratory insufficiency. This case helps to fill that gap by providing a practical framework for managing this complex scenario, emphasizing transthoracic echocardiography (TTE)-guided fluid therapy, lung-protective ventilation, and thromboelastography (TEG)-guided coagulation management. Case presentation A 66-year-old female patient (height 150 cm, weight 39 kg, BMI 17.3 kg/m²) was transferred to our hospital for intrahepatic bile duct stones with obstructive jaundice and hepatic dysfunction. Following failed endoscopic retrograde cholangiopancreatography and inadequate percutaneous transhepatic biliary drainage at an outside hospital, she developed hepatic encephalopathy and type II respiratory failure; both resolved with conservative management. Due to persistent fever and jaundice, she underwent laparoscopic cholecystectomy, choledochoscopy-assisted stone extraction, and T-tube drainage. The patient had a 20-year history of bronchiectasis with six prior hospitalizations for biliary and pulmonary infections. No history of hypertension, coronary artery disease, or diabetes. On admission, she was conscious but fatigued, with severe jaundice and bilateral lower extremity edema. Vital signs: blood pressure 105/58 mmHg, heart rate 82 bpm, peripheral oxygen saturation (SpO₂) 94% on 2 L/min oxygen via nasal cannula. Coarse breath sounds with scattered rhonchi and crackles, and a pleural friction rub were audible in both lungs. Tenderness and rebound tenderness were present in the left upper abdomen. Contrast-enhanced CT revealed: situs inversus totalis with polysplenia syndrome (Fig. 1); agenesis of the hepatic inferior vena cava with azygos continuation (Fig. 2); bilateral bronchiectasis with consolidation (Fig. 3); and multiple intrahepatic bile duct stones (Fig. 1B). Echocardiography demonstrated mirror-image dextrocardia, mild left atrial enlargement, and an ejection fraction of 68%. Key laboratory findings: Hemoglobin 89 g/L, PT 21.2 s, INR 1.9, D-dimer 3011 ng/mL; total bilirubin 285.6 μmol/L, ALT 123 U/L, GGT 154 U/L; albumin 31.1 g/L; K+ 3.1 mmol/L; procalcitonin 2.88 ng/mL. Model for End-Stage Liver Disease score 24. Arterial blood gas (on 2 L/min oxygen): PaO₂ 67 mmHg, PaCO₂ 38 mmHg. Fig. 1Contrast-enhanced CT scan of the chest and abdomen with three-dimensional reconstruction. A Coronal view showing situs inversus totalis: (a) heart, (b) liver, and (c) stomach. B Axial view showing: (a) polysplenia (multiple spleens of varying sizes), (b) aorta, (c) dilated azygos vein, and (d) multiple intrahepatic bile duct stones Contrast-enhanced CT scan of the chest and abdomen with three-dimensional reconstruction. A Coronal view showing situs inversus totalis: (a) heart, (b) liver, and (c) stomach. B Axial view showing: (a) polysplenia (multiple spleens of varying sizes), (b) aorta, (c) dilated azygos vein, and (d) multiple intrahepatic bile duct stones Fig. 2Contrast-enhanced axial chest CT images showing multiple vascular abnormalities. A: (a) pulmonary trunk, (b) aorta, (c) dilated azygos vein draining into the superior vena cava (SVC), and (d) SVC. B: (a) confluence of the hepatic veins draining into the right atrium, (b) aorta, (c) agenesis of the hepatic segment of the inferior vena cava with azygos continuation, and (d) liver Contrast-enhanced axial chest CT images showing multiple vascular abnormalities. A: (a) pulmonary trunk, (b) aorta, (c) dilated azygos vein draining into the superior vena cava (SVC), and (d) SVC. B: (a) confluence of the hepatic veins draining into the right atrium, (b) aorta, (c) agenesis of the hepatic segment of the inferior vena cava with azygos continuation, and (d) liver Fig. 3Contrast-enhanced axial chest CT image. The arrow indicates cystic bronchiectasis Contrast-enhanced axial chest CT image. The arrow indicates cystic bronchiectasis Preoperative assessment Four major, interacting risk factors were identified: (1) Bilateral bronchiectasis with active infection and pleural effusion, indicative of severely limited pulmonary reserve; (2) Dextrocardia and IVC anomaly, predisposing the patient to unpredictable hemodynamic instability during positive-pressure ventilation and pneumoperitoneum; (3) Child-Pugh C cirrhosis with coagulopathy and portal hypertension, increasing bleeding risk and altering drug metabolism; (4) Low BMI, active cholangitis, and hypoalbuminemia, reflecting a compromised nutritional and immune status. ASA physical status was class IV. Ethics statement This study was approved by the Institutional Ethics Committee of Shenzhen Bao’an Traditional Chinese Medicine Hospital (Ethics approval number: KY-2026-012-01). While conscious, the patient was critically ill, leaving her unable to comprehend the surgical complexity required for legally valid consent. Thus, written consent was obtained from her legal representative (son), with her verbal assent. As the patient deceased before submission, publication consent was obtained from her daughter per ICMJE and BMC policies. Anesthesia management Monitoring and preparation Upon arrival in the operating room, standard monitoring was initiated. Vital signs: noninvasive blood pressure 102/48 mmHg, heart rate 88 bpm, temperature 36.9 °C, and SpO₂ 85%–87% on room air. Due to SIT, electrocardiographic leads were placed in a mirror-image arrangement: left arm (LA), left leg (LL), and precordial (V) leads on the right chest; right arm (RA) and right leg (RL) leads on the left chest. A right radial artery catheter was inserted for invasive blood pressure monitoring, and ultrasound-guided left internal jugular vein catheterization was performed. Bispectral index (BIS) was 90. Oxygen was administered via face mask at 6 L/min; 200 mL of compound sodium lactate was infused; and 40 mg of methylprednisolone was given intravenously. Induction Anesthesia was induced using topical laryngeal anesthesia (2% lidocaine) followed by slow administration of: Sufentanil 0.26 µg/kg (total 10 µg; boluses of 5 µg + 5 µg), etomidate 0.21 mg/kg (total 8 mg), and cisatracurium 0.15 mg/kg (total 6 mg). This was followed immediately by continuous infusions of propofol 3.5 mg/(kg·h) and remifentanil 0.25 µg/(kg·min). Tracheal intubation was facilitated by a video laryngoscope, and mechanical ventilation was commenced in pressure-controlled ventilation with volume guarantee (PCV-VG) mode. Maintenance Anesthesia was maintained with propofol 3.0–5.0 mg/(kg·h) (total 750 mg over 320 min) and remifentanil 0.15–0.3 µg/(kg·min) (total 3.1 mg over 320 min) adjusted to keep BIS 40–60 and mean arterial pressure 65–85 mmHg. Intermittent cisatracurium boluses were given as needed. Ventilation strategy A lung-protective ventilation strategy was implemented: initial tidal volume 7 mL/kg (ideal body weight), respiratory rate 12 bpm, positive end-expiratory pressure 5 cmH₂O, and FiO₂ 0.4. Adjustments were guided by arterial blood gas analysis and end-tidal carbon dioxide (EtCO₂), with intermittent lung recruitment. During surgery, EtCO₂ progressively rose to 59 mmHg (PaCO₂ 79.2 mmHg, pH 7.17), exceeding our predefined limits (permissive hypercapnia target: PaCO₂ ≤ 65 mmHg and pH ≥ 7.20). This prompted the following interventions: the respiratory rate was increased to 18 bpm, pneumoperitoneum pressure was reduced from 12 to 10 mmHg, and tidal volume was increased to 8 mL/kg (ideal body weight). Post-intervention, PaCO₂ stabilized at 60 mmHg with EtCO₂ 45 mmHg. Hemodynamic and fluid management A restrictive fluid strategy combined with low-dose norepinephrine infusion was employed. Due to agenesis of the IVC hepatic segment and relative contraindications to transesophageal echocardiography (TEE), volume status was assessed via transthoracic echocardiography (TTE). In the parasternal short-axis view, left ventricular end-diastolic area (LVEDA) and cavity obliteration (‘kissing papillary muscles’ sign) were evaluated. Hypovolemia (LVEDA < 10 cm² or positive kissing sign) triggered a 200 mL fluid bolus. Normovolemia was defined as LVEDA 10–18 cm² without cavity obliteration. Norepinephrine was infused at 0.05–0.2 µg/(kg·min) (total 0.9 mg over 320 min) and titrated to maintain arterial blood pressure 98–130/50–60 mmHg. Total fluid intake: 1000 mL compound sodium lactate and blood products (4 units of packed red blood cells, 1000 mL fresh frozen plasma, and 20 units of cryoprecipitate). Hemoglobin was titrated to ≥ 9 g/dL via arterial blood gas analysis, accounting for respiratory insufficiency. Coagulation management employed TEG-guided goal-directed therapy. Given the high risk of volume overload from respiratory insufficiency and IVC anomaly, a restrictive transfusion strategy was prioritized, tolerating moderate hypocoagulability to minimize fluid administration. Transfusion thresholds: fresh frozen plasma for R > 10 min, cryoprecipitate for α-angle < 45°, platelets for MA < 35 mm (target MA > 35 mm). Estimated blood loss: 1000 mL; urine output: 800 mL. Core temperature was maintained at 36.5 °C with a warming device. Postoperative transition Total surgical duration was 320 min. At closure, ropivacaine was infiltrated into the incision sites. One hour after admission to the ICU, she regained consciousness with stable vital signs and was extubated. Postoperative follow-up showed improved mental status, reduced jaundice, SpO₂ 96% on 2 L/min oxygen, and improved laboratory parameters. She was discharged from the ICU to the general ward on postoperative day 6. Discussion The primary challenge in this case was the rare coexistence of three high-risk factors: SIT with IVC anatomic variation, decompensated cirrhosis, and respiratory insufficiency. Previous literature indicates that each condition individually presents significant anesthetic challenges. Specifically, regarding SIT and associated visceral anomalies, prior reports have described difficulties in central venous access, airway management, and surgical positioning [3–7]. For patients with end-stage liver disease undergoing non-hepatic surgery, the literature emphasizes risks of coagulopathy, hemodynamic instability, and drug metabolism alterations [8]. For pre-existing respiratory insufficiency, perioperative strategies focus on protective ventilation and postoperative respiratory support [9]. However, we found no previous study describing anesthesia management for the simultaneous presence of these three conditions. This case highlights the critical importance of individualized anesthesia planning for patients with rare anatomical and multisystem comorbidities. Anesthesia strategy for anatomical variations In patients with SIT, electrocardiographic leads are placed in a mirror-image configuration (as described in the Case presentation). For central venous access, the left internal jugular vein is preferred because it provides a direct pathway to the superior vena cava. Our patient had a more complex venous anomaly: agenesis of the hepatic segment of the IVC with azygos continuation, where the hepatic veins drained directly into the right atrium, and lower-body venous return relied on a dilated azygos system. This anatomy makes volume assessment based on IVC diameter or its respiratory changes invalid. Given the relative contraindications to TEE (esophageal and gastric varices with coagulopathy) [10], we used TTE as an alternative. Anesthesia management of decompensated cirrhosis For Child-Pugh C cirrhosis, intraoperative goals include maintaining hepatic perfusion and oxygen delivery while avoiding further liver injury. Regarding drug selection, priority should be given to agents that do not rely on hepatic metabolism or have relatively safe metabolic profiles. For induction, etomidate was chosen for its hemodynamic stability, and sufentanil was given only during induction in small divided doses to minimize accumulation. Propofol has reduced clearance in patients with cirrhosis, but its half-life is only modestly prolonged [11]. Remifentanil is hydrolyzed by plasma esterases, independent of hepatic function [12]. Cisatracurium undergoes Hofmann elimination, with no hepatic or renal dependence [13]. To guide fluid therapy, we used TTE to measure LVEDA and the “kissing papillary muscles” sign (see Anesthesia management section). On this basis, low-dose norepinephrine was administered to maintain critical organ perfusion pressure, titrated to cardiac filling status. In this patient, lower-body venous return relied on the compensatorily dilated azygos system. Pneumoperitoneum raises intra-abdominal and intrathoracic pressure, which can directly compress the azygos vein and slow its flow, lowering cardiac preload. Higher intrathoracic pressure may also increase resistance to azygos venous return. To counter these effects, we (1) kept pneumoperitoneum ≤ 12 mmHg; (2) limited PEEP to ≤ 5 cmH₂O; (3) used TTE to track left ventricular end-diastolic area to maintain appropriate preload; and (4) used the lowest effective dose of norepinephrine to maintain systemic blood pressure, avoiding high doses of norepinephrine to prevent potential interference with venous return, ensuring stable cardiac output [14]. Coagulopathy is a major complication of end-stage liver disease [15]. We monitored coagulation with TEG and gave fresh frozen plasma and cryoprecipitate based on TEG findings, clinical assessment, and surgical field oozing. The patient had no postoperative intra-abdominal bleeding or puncture site hematoma. Surgical approach selection is integral to anesthesia management. Despite pneumoperitoneum risks in this patient with IVC anomalies and respiratory insufficiency, the multidisciplinary team prioritized minimizing surgical trauma and blood loss. Laparoscopy was favored over open surgery because it reduces bleeding (critical for Child-Pugh C patients with coagulopathy) and avoids a large incision, thereby mitigating postoperative respiratory compromise from pain and splinting. Lung-protective ventilation for respiratory insufficiency The patient had preoperative bronchiectasis with respiratory insufficiency and a prior history of respiratory failure. During laparoscopic surgery, pneumoperitoneum inevitably elevates the diaphragm and reduces lung volume; moreover, CO₂ absorption may induce hypercapnia. Initially, a lung-protective ventilation strategy combined with permissive hypercapnia was considered based on established physiological principles [16–19]: (1) Patients with cirrhosis often have a tendency toward respiratory alkalosis [16]; acute moderate hypercapnia may improve tissue oxygen delivery [17]. (2) Avoiding excessive ventilation helps prevent auto-PEEP and a decrease in cardiac output [18]. (3) Patients with bronchiectasis have heterogeneous lung parenchymal compliance and are susceptible to barotrauma; PCV-VG delivers the target tidal volume at the lowest possible airway pressure and accommodates dynamic changes in lung compliance during pneumoperitoneum [19]. However, due to anatomical variations and severe adhesions prolonging the operation, PaCO₂ progressively rose, peaking at 79 mmHg late in the procedure. We immediately implemented ventilatory adjustments: increasing respiratory rate, reducing pneumoperitoneum pressure, and cautiously raising tidal volume within plateau pressure limits. These interventions proved effective, stabilizing PaCO₂ within the target range at 60 mmHg until the end of surgery. Postoperatively, the patient was transferred to the ICU with the tracheal tube in place, allowing a buffer period for gradual correction of hypercapnia. No adverse events related to hypercapnia were observed. In this context, permissive hypercapnia was not routine. Due to the anatomical complexity and coagulopathy, conversion to open surgery posed a risk of massive hemorrhage. Thus, the multidisciplinary team ultimately deemed this the “lesser of two harms,” accepting transient hypercapnia to avoid greater surgical morbidity. Multidisciplinary collaboration and limitations Successful management relied on pre-procedural multidisciplinary planning and real-time collaboration among anesthesia, hepatobiliary surgery, and ICU teams. Limitations include the inherent generalizability constraints of a single case report and the operator dependence of TTE findings. Notably, the lack of continuous hemodynamic monitoring, specifically TEE (contraindicated due to esophageal varices) and pulse indicator continuous cardiac output (deemed high risk due to coagulopathy and the need for a large-bore femoral catheter), precluded real-time assessment of volume status. Non-invasive cardiac output monitoring was also unavailable. Although a radial artery catheter was placed for pressure monitoring, the inability to quantify cardiac output or dynamic preload continuously likely delayed interventions during acute hemodynamic shifts. Given the extreme rarity, large-scale studies are impractical; accumulation of similar cases via multicenter registries may help validate these strategies. Moreover, the lack of long-term follow-up data and standardized objective measures for postoperative pulmonary and hepatic function precludes assessing the durability of the intervention and late complications. Conclusion An individualized anesthesia strategy, incorporating monitoring adapted to anatomical variations, hepatically-sparing drug selection, TTE-guided volume management, and lung-protective ventilation with permissive hypercapnia, enabled safe laparoscopic biliary surgery in a patient with SIT, IVC anomaly, decompensated cirrhosis, and respiratory insufficiency. This report provides a practical framework for similar complex cases.